Marcus, I would take this opportunity to highlight the amazing work that's been done by the folks at Ornge in getting vaccination rates in the 90% range in a number of communities, despite immense logistical challenges. This is one of the aspects of the mass vaccination efforts in communities. It's not over yet. A lot of communities need to get that second dose, and we'll be there to help them, whether it's the assets of the Government of Canada or leveraging those that exist in the province. Whatever works, we're there to help.
I quoted aggregate numbers at the beginning. I don't like generalizing because the rollout is still a little uneven and there are some unnatural fault lines. However, as a generalization, if you take the 200,000-plus vaccinations that have occurred in indigenous communities or in the territories, we're halfway there in terms of the indigenous population. Now that may vary from a southern to a northern community, which is why I hesitate to generalize, but this is a race against the clock, particularly in the face of a potential third wave that is fuelled by variants of concern.
The suite of tools we deploy includes point-of-care testing. We have about 400 units deployed now, including the GeneXpert ones, which were the early leaders and the reliable ones. However, whether it's the ID NOW or others, that's to help that point-of-care testing, which is complementing not only the vaccine rollout but the secure fly in, fly out communities with our health workers. The last thing they want to do is be a vector of spread. That continues, and we continue to learn, but I think Canadians can be quite proud of this, because we really focused on—